The early-bird rate for the AI4Biotech Session – Biotech AI Compass ends soon. Join BioM and Steadforce on 19 November 2026 to assess your organisation’s AI readiness, prioritise relevant initiatives and develop a focused roadmap for implementation.
Many biotech and life science organisations are exploring the potential of artificial intelligence. But deciding which initiatives genuinely fit an organisation, where to begin and how to move from ambition to implementation remains a challenge.
The AI4Biotech Session – Biotech AI Compass, jointly delivered by BioM and Steadforce, supports leaders and decision-makers in addressing these questions through a structured, hands-on process.
During the session, participants will:
- assess their organisation’s AI readiness and identify key bottlenecks
- reflect on strategic ambition and risk tolerance
- evaluate and prioritise relevant AI initiatives
- develop a focused roadmap with clear actions and ownership
- exchange perspectives with other leaders from biotech and life sciences
The detailed agenda is now available. It includes an impulse and fireside chat with Thought Leaders Dr. Anna Bauer-Mehren (Roche Diagnostics & Bavarian AI Council), and Prof. Dr. Carsten Marr (Helmholtz Munich & LMU).
Implementation support continues after the session: Participants can benefit from up to three 90-minute follow-up check-ins with experts from Steadforce. These check-ins are designed to help maintain momentum and translate workshop outcomes into concrete implementation steps.
Event details
Date: 19 November 2026, 9 am – 8 pm
Venue: BioM, Room Munich, Am Klopferspitz 19a, Martinsried (near Munich)
Language: English
Special rates are available for academia and start-ups, as well as a team discount. No technical AI background is required.
Places are limited to ensure an interactive setting, individual reflection and meaningful peer exchange.
View the agenda and secure your place at the early-bird rate